JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 903 articles

Articles by James Calloway

Vertiv Gains Investment-Grade Rating After Strong Earnings
Earnings

Vertiv Gains Investment-Grade Rating After Strong Earnings

Vertiv Holdings shares eased slightly Friday but posted a nearly 20% weekly gain after S&P upgraded its credit rating to investment-grade BBB- on strong earnings and surging orders.

VRT
Spotify Shares Rebound 2.8% to $458 After Volatile Week
Earnings

Spotify Shares Rebound 2.8% to $458 After Volatile Week

Spotify shares gained 2.8% to close at $458.34 on Friday, rebounding from Thursday's sharp decline. The stock has risen approximately 10.5% since Monday's close.

SPOT
Intuit Nears $400 as AI Fears Weigh Ahead of Earnings
Earnings

Intuit Nears $400 as AI Fears Weigh Ahead of Earnings

Intuit shares closed slightly higher at $399.40 but remain down sharply for the year due to AI-related selling pressure. All eyes are on the company's fiscal Q2 report due February 26.

INTU
Goldman Sachs Legal Chief Exits Amid Epstein Scandal Fallout
Regulation

Goldman Sachs Legal Chief Exits Amid Epstein Scandal Fallout

Goldman Sachs' top lawyer Kathy Ruemmler steps down following disclosures about her past interactions with Jeffrey Epstein, as the bank's shares face volatility.

GS UBS
Rivian Soars 27% on Q4 Profit, 2026 Outlook; EV Sector Mixed
Earnings

Rivian Soars 27% on Q4 Profit, 2026 Outlook; EV Sector Mixed

Rivian Automotive surged 26.7% following a profitable Q4 and strong 2026 delivery guidance, while other EV stocks showed mixed performance ahead of the holiday break.

RIVN TSLA LCID NIO
Booking Holdings Hits 52-Week Low Ahead of Q4 Earnings Report
Earnings

Booking Holdings Hits 52-Week Low Ahead of Q4 Earnings Report

Booking Holdings shares touched a 52-week low of $4,071.60 on Friday ahead of its fourth-quarter earnings report scheduled for February 18.

BKNG EXPE ABNB
Eli Lilly Builds $1.5B Inventory for Obesity Pill Ahead of FDA Decision
Regulation

Eli Lilly Builds $1.5B Inventory for Obesity Pill Ahead of FDA Decision

Eli Lilly shares edged higher Friday as the company disclosed a $1.5 billion inventory build for its experimental weight-loss pill orforglipron, awaiting an FDA decision this spring.

LLY NVO
Visa Shares Drop on Legal Fee Disclosure, Stock Exchange Plan
Regulation

Visa Shares Drop on Legal Fee Disclosure, Stock Exchange Plan

Visa shares declined 3.1% Friday following a regulatory disclosure that ties a proposed Class B stock exchange to a significant reduction in legal interchange fees. The company estimates those fees at $39.4 billion as of October 2025.

V
Cloudflare Surges on Strong Outlook and Major Investor Backing
Earnings

Cloudflare Surges on Strong Outlook and Major Investor Backing

Cloudflare shares climbed nearly 6% in extended trading after the company issued a robust 2026 revenue forecast and reported a significant increase in its contract backlog. A major institutional investor also disclosed a sizable stake in the firm.

NET AKAM
Analog Devices Gains on Barclays Upgrade Ahead of Earnings
Earnings

Analog Devices Gains on Barclays Upgrade Ahead of Earnings

Analog Devices shares advanced following an upgrade to Overweight by Barclays, which raised its price target to $375. The chipmaker reports quarterly results next week.

ADI
Moderna Shares Rise on Q4 Beat, Flu Vaccine Faces FDA Hurdle
Earnings

Moderna Shares Rise on Q4 Beat, Flu Vaccine Faces FDA Hurdle

Moderna shares advanced roughly 5% late Friday after reporting better-than-expected Q4 revenue. The company reaffirmed its 2026 growth targets despite an FDA setback for its seasonal flu vaccine.

MRNA MRK
McDonald's Shares Dip After CEO Files to Sell $8.5M in Stock
Earnings

McDonald's Shares Dip After CEO Files to Sell $8.5M in Stock

McDonald's shares declined in extended trading following a CEO stock sale filing, even as the company posted robust quarterly results and received a Buy rating upgrade from Argus.

MCD